Logos Global Management LP Forma Therapeutics Holdings, Inc. Transaction History

Logos Global Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$8.34 - $14.69 $13.3 Million - $23.5 Million	-1,600,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$13.6 - $24.89 $7 Million - $12.8 Million	-515,000 Reduced 24.35%	1,600,000 $22.8 Million
Q3 2021 Nov 15, 2021	BUY	$21.22 - $25.7 $19.1 Million - $23.1 Million	900,000 Added 74.07%	2,115,000 $49 Million
Q2 2021 Aug 16, 2021	SELL	$22.86 - $30.95 $4.46 Million - $6.04 Million	-195,000 Reduced 13.83%	1,215,000 $30.2 Million
Q1 2021 May 17, 2021	BUY	$24.58 - $42.82 $245,799 - $428,200	10,000 Added 0.71%	1,410,000 $39.5 Million
Q4 2020 Feb 16, 2021	BUY	$34.9 - $51.08 $7.92 Million - $11.6 Million	226,812 Added 19.33%	1,400,000 $48.9 Million
Q3 2020 Nov 16, 2020	SELL	$32.95 - $50.25 $3.52 Million - $5.37 Million	-106,812 Reduced 8.34%	1,173,188 $58.5 Million
Q2 2020 Aug 14, 2020	BUY	$39.0 - $46.49 $49.9 Million - $59.5 Million	1,280,000 New	1,280,000 $59.5 Million

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Logos Global Management LP with notifications on news.